155 related articles for article (PubMed ID: 1316120)
1. Evoked potentials in cerebrotendinous xanthomatosis and effect induced by chenodeoxycholic acid.
Mondelli M; Rossi A; Scarpini C; Dotti MT; Federico A
Arch Neurol; 1992 May; 49(5):469-75. PubMed ID: 1316120
[TBL] [Abstract][Full Text] [Related]
2. Cerebrotendinous xanthomatosis: 11-year treatment with chenodeoxycholic acid in five patients. An electrophysiological study.
Mondelli M; Sicurelli F; Scarpini C; Dotti MT; Federico A
J Neurol Sci; 2001 Sep; 190(1-2):29-33. PubMed ID: 11574103
[TBL] [Abstract][Full Text] [Related]
3. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
Pedley TA; Emerson RG; Warner CL; Rowland LP; Salen G
Ann Neurol; 1985 Oct; 18(4):517-8. PubMed ID: 4073846
[TBL] [Abstract][Full Text] [Related]
4. Somatosensory and motor evoked potentials in the assessment of cerebrotendinous xanthomatosis before and after treatment with chenodeoxycholic acid: a preliminary study.
Restuccia D; Di Lazzaro V; Servidei S; Colosimo C; Tonali P
J Neurol Sci; 1992 Oct; 112(1-2):139-46. PubMed ID: 1469424
[TBL] [Abstract][Full Text] [Related]
5. Cerebrotendinous xanthomatosis: clinical, electrophysiological and nerve biopsy findings, and response to treatment with chenodeoxycholic acid.
Donaghy M; King RH; McKeran RO; Schwartz MS; Thomas PK
J Neurol; 1990 Jun; 237(3):216-9. PubMed ID: 2196342
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological studies in cerebrotendinous xanthomatosis.
Tokimura Y; Kuriyama M; Arimura K; Fujiyama J; Osame M
J Neurol Neurosurg Psychiatry; 1992 Jan; 55(1):52-5. PubMed ID: 1312580
[TBL] [Abstract][Full Text] [Related]
7. Brainstem auditory evoked potentials and somatosensory evoked potentials in cerebral malaria--a prognostic significance.
Kochar DK; Kumawat BL; Halwai M; Kochar SK; Shubhakaran ; Thanvi I
J Assoc Physicians India; 2000 Mar; 48(3):295-300. PubMed ID: 11229113
[TBL] [Abstract][Full Text] [Related]
8. Neurotoxic effects of n-hexane on the human central nervous system: evoked potential abnormalities in n-hexane polyneuropathy.
Chang YC
J Neurol Neurosurg Psychiatry; 1987 Mar; 50(3):269-74. PubMed ID: 3031221
[TBL] [Abstract][Full Text] [Related]
9. Evoked potentials during isoflurane anaesthesia.
Sebel PS; Ingram DA; Flynn PJ; Rutherfoord CF; Rogers H
Br J Anaesth; 1986 Jun; 58(6):580-5. PubMed ID: 3707793
[TBL] [Abstract][Full Text] [Related]
10. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations.
Moghadasian MH; Salen G; Frohlich JJ; Scudamore CH
Arch Neurol; 2002 Apr; 59(4):527-9. PubMed ID: 11939886
[TBL] [Abstract][Full Text] [Related]
11. Effects of spontaneous chronic hypoglycemia on central and peripheral nervous system in insulinoma patients before and after surgery: a neurophysiological follow-up.
Pozzessere G; Valle E; D'Alessio C; Soldati G; Pierelli F; Leonetti F; Foniciello M; Tamburrano G
J Clin Endocrinol Metab; 1997 May; 82(5):1447-51. PubMed ID: 9141531
[TBL] [Abstract][Full Text] [Related]
12. Evoked potential studies in mitochondrial encephalomyopathy.
Tsuji S; Uozumi T; Nakano S; Ohnishi A; Murai Y
Arch Neurol; 1990 Apr; 47(4):465-7. PubMed ID: 2157382
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic value of somatosensory evoked potentials in the diseases of peripheral nervous system.
Constantinovici A
Neurol Psychiatr (Bucur); 1989; 27(2):111-25. PubMed ID: 2551030
[TBL] [Abstract][Full Text] [Related]
14. Somatosensory and visual evoked potentials in insulin-dependent diabetics with mild peripheral neuropathy.
Collier A; Reid W; McInnes A; Cull RE; Ewing DJ; Clarke BF
Diabetes Res Clin Pract; 1988 Sep; 5(3):171-5. PubMed ID: 3219989
[TBL] [Abstract][Full Text] [Related]
15. [A central nerve conduction study in hypothyroidism: before and after thyroxine replacement].
Lai CL; Lin RT; Tai CT; Liu CK; Howng SL
Kaohsiung J Med Sci; 1998 Dec; 14(12):743-50. PubMed ID: 9887642
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid in three siblings.
Chang WN; Kuriyama M; Chee EC
J Formos Med Assoc; 1994 Mar; 93(3):256-9. PubMed ID: 7920069
[TBL] [Abstract][Full Text] [Related]
17. Schwartz-Jampel syndrome: evidence of central nervous system dysfunction.
Singh B; Biary N; Jamil AA; al-Shahwan SA
J Child Neurol; 1997 Apr; 12(3):214-7. PubMed ID: 9130098
[TBL] [Abstract][Full Text] [Related]
18. [Multimodal evoked potentials in malabsorption syndrome].
Paradowski B; Waszczuk E; Bilińska M; Paradowski L; Podemski R
Pol Merkur Lekarski; 2001 Dec; 11(66):499-502. PubMed ID: 11899847
[TBL] [Abstract][Full Text] [Related]
19. EEG in cerebrotendinous xanthomatosis (CTX).
Berginer VM; Radwan H; Korczyn AD; Kott E; Salen G; Shefer S
Clin Electroencephalogr; 1982 Apr; 13(2):89-96. PubMed ID: 7094358
[No Abstract] [Full Text] [Related]
20. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
Berginer VM; Salen G; Shefer S
N Engl J Med; 1984 Dec; 311(26):1649-52. PubMed ID: 6504105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
